rs104894021
From SNPedia
| Orientation | minus |
| Stabilized | minus |
| Geno | Mag | Summary |
|---|---|---|
| (C;C) | 0 | common in clinvar |
| Make rs104894021(C;G) |
| Make rs104894021(G;G) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 7 |
| Position | 150951629 |
| Gene | KCNH2 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs104894021 |
| dbSNP (classic) | rs104894021 |
| ClinGen | rs104894021 |
| ebi | rs104894021 |
| HLI | rs104894021 |
| Exac | rs104894021 |
| Gnomad | rs104894021 |
| Varsome | rs104894021 |
| LitVar | rs104894021 |
| Map | rs104894021 |
| PheGenI | rs104894021 |
| Biobank | rs104894021 |
| 1000 genomes | rs104894021 |
| hgdp | rs104894021 |
| ensembl | rs104894021 |
| geneview | rs104894021 |
| scholar | rs104894021 |
| rs104894021 | |
| pharmgkb | rs104894021 |
| gwascentral | rs104894021 |
| openSNP | rs104894021 |
| 23andMe | rs104894021 |
| SNPshot | rs104894021 |
| SNPdbe | rs104894021 |
| MSV3d | rs104894021 |
| GWAS Ctlg | rs104894021 |
| Max Magnitude | 0 |
| ClinVar | |
|---|---|
| Risk | rs104894021(A;A) rs104894021(G;G) |
| Alt | rs104894021(A;A) rs104894021(G;G) |
| Reference | Rs104894021(C;C) |
| Significance | Pathogenic |
| Disease | Short QT syndrome 1 Short QT syndrome |
| Variation | info |
| Gene | KCNH2 |
| CLNDBN | Short QT syndrome 1 short QT syndrome |
| Reversed | 1 |
| HGVS | NC_000007.13:g.150648717G>C; NC_000007.13:g.150648717G>T |
| CLNSRC | OMIM Allelic Variant UniProtKB (protein) |
| CLNACC | RCV000015517.27, RCV000057981.3, RCV000015518.23, RCV000057980.3, |
[PMID 14676148] Sudden death associated with short-QT syndrome linked to mutations in HERG.
[PMID 15828882] Short QT syndrome and atrial fibrillation caused by mutation in KCNH2.
[PMID 19088443] Biophysical characterization of the short QT mutation hERG-N588K reveals a mixed gain-and loss-of-function.
[PMID 19439805] Comparative effects of the short QT N588K mutation at 37 degrees C on hERG K+ channel current during ventricular, Purkinje fibre and atrial action potentials: an action potential clamp study.
[PMID 19501051
] hERG1a/1b heteromeric currents exhibit amplified attenuation of inactivation in variant 1 short QT syndrome.
